These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 13110893)

  • 1. [Lytic cocktail in the treatment of juvenile chronic obliterating arterial disease].
    NICOLOSI G
    Minerva Med; 1953 Sep; 44(70):497-9. PubMed ID: 13110893
    [No Abstract]   [Full Text] [Related]  

  • 2. [Research on regional arterial and venous oxygen levels in chronic obliterating arteriopathies in young persons during the treatment with lytic cocktail].
    FLORENA M; MANNINO R; RODOLICO A
    G Ital Chir; 1956 Jun; 12(6):347-61. PubMed ID: 13366016
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lytic cocktail in therapy of chronic obliterating arteriopathy].
    D'ANCONA G
    Minerva Chir; 1955 Feb; 10(3):120-6. PubMed ID: 14369777
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term results of chronic obliterative arteriopathies treated with lytic-cocktail.
    BAZAN M
    Panminerva Med; 1959 Oct; 1():240-2. PubMed ID: 13797848
    [No Abstract]   [Full Text] [Related]  

  • 5. [Proposed new durg cocktail in medical therapy of chronic obliterating arteriopathy].
    VASILE B
    Gazz Med Ital; 1958 Mar; 117(3):87-90. PubMed ID: 13538196
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pyruvate levels of arterial & venous blood in patients with arterial diseases administered lytic cocktail].
    RODOLICO A; FLORENA M
    Riv Patol Clin; 1957 Dec; 12(12):665-76. PubMed ID: 13519017
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preliminary results in the use of trypsin in the treatment of chronic peripheral obliterating arterial diseases].
    CONTI A; MAZZEO F
    Minerva Chir; 1957 May; 12(9):419-25. PubMed ID: 13451265
    [No Abstract]   [Full Text] [Related]  

  • 8. [Plethysmographic data on the effects of intra-arterial insulin in non-diabetic chronic peripheral obliterating arteriopathies].
    MEDICI A; CONTORNI L; SCOGNAMIGLIO F
    G Clin Med; 1957 Jul; 38(7):989-1013. PubMed ID: 13474377
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lanthasol aerosol in the treatment of obliterating peripheral arterial diseases and in coronary disease].
    NARDI FL
    Gazz Med Ital; 1958 Aug; 117(8):333-9. PubMed ID: 13574395
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anticoagulant therapy of chronic obliterating peripheral arteriopathy].
    TATTONI G; MALCHIODI C
    Arch Ital Chir; 1954; 77(3):169-88. PubMed ID: 13181602
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intra-arterial curare therapy of peripheral obliterating arteriopathy].
    ENRIA G
    Minerva Cardioangiol; 1957 Oct; 5(10):461-3. PubMed ID: 13503741
    [No Abstract]   [Full Text] [Related]  

  • 12. [Is obliterating arteriopathy of the lower limbs still the poor member of the arterial disease family? What can be done?].
    Blacher J
    J Mal Vasc; 2007 Apr; 32(2):73-4. PubMed ID: 17498900
    [No Abstract]   [Full Text] [Related]  

  • 13. [Arteriovenous fistula in the picture of chronic juvenile obliterating arterial disease].
    CADILI G
    Minerva Chir; 1956 Nov; 11(22):1121-31. PubMed ID: 13399836
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of disopropylammonium dichloroacetate (DIEDI) in the treatment of chronic peripheral arteriosclerotic obliterating arteriopathies].
    GUAGLIANO G; STOPPANI L; VITTORI C
    Minerva Med; 1960 Sep; 51():2931-5. PubMed ID: 13709324
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bogomoletz serum in therapy of chronic peripheral obliterating arteriopathy].
    VERGANI G
    Gazz Med Ital; 1958 Jan; 117(1):4-5. PubMed ID: 13524597
    [No Abstract]   [Full Text] [Related]  

  • 16. [Photoplethysmographic changes after lumbar gangliectomy in chronic peripheral obliterating arterial diseases].
    FABI M; MALAGU I; FUSAROLIP ; RANERID
    Arcisp S Anna Ferrara; 1962; 15():409-24. PubMed ID: 13891187
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic innovations in chronic peripheral arteriosclerotic obliterating arteriopathies].
    GUAGLIANO G; STOPPANI L; CONTI PG
    Angiologia; 1960; 12():323-36. PubMed ID: 13709323
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the electrophoretic picture of lipoproteins and glycoprotein fractions in arterial and venous blood of patients of arterial diseases after drug cocktail therapy].
    SOMMARIVA V; RAPISARDA LM
    Riv Patol Clin; 1958 Feb; 13(2):41-62. PubMed ID: 13543270
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes of the arteriolo-capillary circulation in subjects of chronic peripheral obliterating arteriopathy after treatment with 1, 1-(beta-hydroxypropyl)-theobromine].
    GUAGLIANO G; STOPPANI L; VITTORI F
    Minerva Med; 1959 Nov; 50():3815-9. PubMed ID: 13829927
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of obliterating arteriopathies of the lower extremities].
    DI CIO OA; BUZZI A
    Dia Med; 1960 Dec; 32():2773-82. PubMed ID: 13722465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.